Home LiteratureArticle Details
PMID: 7768606 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi.

Infection and immunity ·Vol. 63 ·No. 6 ·1995-06-00 ·Pages 2255-61

Barthold SW, Fikrig E, Bockenstedt LK, Persing DH

Abstract

Outer surface protein A (OspA), which is abundantly expressed in cultured Borrelia burgdorferi, appears to be down-regulated or masked following low-dose infection, and OspA immunization did not prevent infection, dissemination, or disease development with host-adapted spirochetes. Seroconversion of mice to B. burgdorferi OspA depended on dose and viability of inoculated spirochetes. Mice inoculated with > 10(4) live spirochetes and > 10(7) heat-killed spirochetes seroconverted to OspA, but mice inoculated with fewer spirochetes did not seroconvert to OspA at 2 weeks after inoculation. Growth temperature of spirochetes was not a factor for infectious dose or seroconversion to OspA. Spirochetes grown at 30, 34, or 38 degrees C had the same median infectious dose. Growth temperature did not influence infectious dose when mice were inoculated intraperitoneally or intradermally and did not influence dose-related immunologic recognition of OspA. Mice hyperimmunized with recombinant OspA-glutathione S-transferase (GT) fusion protein or GT (controls) were challenged by syringe inoculation with 10(3) spirochetes or by transplantation of infected skin from syngenic mice infected for 2 or 8 weeks. OspA-GT-immunized mice resisted syringe challenge but developed disseminated infections following transplantation of infected skin. Identical results were obtained in mice passively immunized with hyperimmune serum to OspA-GT or GT and then challenged by syringe or infected skin transplant. The number of spirochetes in infected skin, determined by quantitative PCR directed toward both plasmid and genomic targets, was less than the syringe challenge dose.

MeSH Terms
Adaptation, Physiological Animals Antigens, Surface/immunology Bacterial Outer Membrane Proteins/immunology Bacterial Vaccines Borrelia burgdorferi Group/immunology Glutathione Transferase/immunology Immunization Lipoproteins Mice Mice, Inbred C3H Temperature
Chemicals
Antigens, Surface Bacterial Outer Membrane Proteins Bacterial Vaccines Lipoproteins OspA protein Glutathione Transferase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Barthold S W
Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Fikrig E
Bockenstedt L K
Persing D H
References (50)
50 references, click to expand
  1. Chronic Lyme borreliosis in the laboratory mouse.
    Am J Pathol. 1993 Sep;143(3):959-71 PMID: 8362988
  2. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
    Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2909-13 PMID: 7708747
  3. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Vaccine. 1993;11(10):1049-54 PMID: 8212826
  4. Antigenic stability of Borrelia burgdorferi during chronic infections of immunocompetent mice.
    Infect Immun. 1993 Dec;61(12):4955-61 PMID: 8225569
  5. Serodiagnosis in early Lyme disease.
    J Clin Microbiol. 1993 Dec;31(12):3090-5 PMID: 8308100
  6. Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients.
    J Infect Dis. 1994 Mar;169(3):668-72 PMID: 8158048
  7. Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A.
    Infect Immun. 1994 Jun;62(6):2625-7 PMID: 8188388
  8. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.
    Infect Immun. 1983 Aug;41(2):795-804 PMID: 6192088
  9. Isolation and cultivation of Lyme disease spirochetes.
    Yale J Biol Med. 1984 Jul-Aug;57(4):521-5 PMID: 6393604
  10. Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.
    J Infect Dis. 1987 Apr;155(4):756-65 PMID: 3819479
  11. Structural features of Borrelia burgdorferi--the Lyme disease spirochete: silver staining for nucleic acids.
    Scanning Microsc Suppl. 1989;3:109-15 PMID: 2482525
  12. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.
    Proc Natl Acad Sci U S A. 1990 May;87(10):3768-72 PMID: 2339119
  13. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.
    Science. 1990 Oct 26;250(4980):553-6 PMID: 2237407
  14. Validity of western immunoblot band patterns in the serodiagnosis of Lyme borreliosis.
    J Clin Microbiol. 1991 Jan;29(1):174-82 PMID: 1993754
  15. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.
    J Infect Dis. 1991 Jul;164(1):123-32 PMID: 1829104
  16. Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans.
    J Clin Microbiol. 1991 Jun;29(6):1162-70 PMID: 1864935
  17. Factors influencing the antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete.
    Scand J Infect Dis Suppl. 1991;77:94-101 PMID: 1947819
  18. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.
    Infect Immun. 1992 Feb;60(2):455-64 PMID: 1730476
  19. Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.
    Infect Immun. 1992 Feb;60(2):657-61 PMID: 1730500
  20. Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi.
    J Clin Microbiol. 1992 Feb;30(2):370-6 PMID: 1537905
  21. Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens.
    J Infect Dis. 1992 Mar;165(3):471-8 PMID: 1531672
  22. Interactions between extracellular Borrelia burgdorferi proteins and non-Borrelia-directed immunoglobulin M antibodies.
    Infect Immun. 1992 Mar;60(3):838-44 PMID: 1541558
  23. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.
    Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5418-21 PMID: 1608951
  24. Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA.
    Protein Expr Purif. 1990 Nov;1(2):159-68 PMID: 2136237
  25. Linear- and circular-plasmid copy numbers in Borrelia burgdorferi.
    J Bacteriol. 1992 Aug;174(16):5251-7 PMID: 1644750
  26. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi.
    Am J Trop Med Hyg. 1992 Aug;47(2):249-58 PMID: 1503192
  27. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.
    J Immunol. 1992 Dec 1;149(11):3648-53 PMID: 1431134
  28. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency.
    Am J Trop Med Hyg. 1992 Nov;47(5):605-13 PMID: 1449201
  29. The major histocompatibility complex-restricted response of recombinant inbred strains of mice to natural tick transmission of Borrelia burgdorferi.
    J Exp Med. 1993 Jan 1;177(1):9-17 PMID: 8418212
  30. Extrachromosomal elements of spirochetes.
    Res Microbiol. 1992 Jul-Aug;143(6):623-8 PMID: 1475522
  31. Western blotting in the serodiagnosis of Lyme disease.
    J Infect Dis. 1993 Feb;167(2):392-400 PMID: 8380611
  32. An OspA antigen-capture enzyme-linked immunosorbent assay for detecting North American isolates of Borrelia burgdorferi in larval and nymphal Ixodes dammini.
    J Clin Microbiol. 1993 Feb;31(2):272-8 PMID: 8432812
  33. Experimental Lyme disease in dogs produces arthritis and persistent infection.
    J Infect Dis. 1993 Mar;167(3):651-64 PMID: 8440936
  34. Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice.
    J Infect Dis. 1993 Apr;167(4):971-5 PMID: 8450262
  35. Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi.
    Infect Immun. 1993 Apr;61(4):1460-7 PMID: 8454350
  36. OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection.
    Infect Immun. 1993 Jun;61(6):2553-7 PMID: 8500891
  37. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens.
    Eur J Clin Microbiol Infect Dis. 1993 Apr;12(4):261-8 PMID: 8513814
  38. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.
    Infect Immun. 1993 Jul;61(7):2774-9 PMID: 7685738
  39. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans.
    Infect Immun. 1993 Jul;61(7):3047-59 PMID: 8514412
  40. Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.
    J Exp Med. 1993 Aug 1;178(2):755-8 PMID: 8340764
  41. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.
    Immunol Lett. 1993 May;36(2):219-26 PMID: 8349316
  42. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
    Infect Immun. 1993 Sep;61(9):3843-53 PMID: 8359905
  43. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.
    JAMA. 1994 Jun 8;271(22):1764-8 PMID: 8196120
  44. A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection.
    Infect Immun. 1994 Jul;62(7):2653-61 PMID: 8005657
  45. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
    Immunol Lett. 1994 Mar;39(3):249-58 PMID: 8034340
  46. Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice.
    Infect Immun. 1994 Aug;62(8):3568-71 PMID: 8039931
  47. Early and specific antibody response to OspA in Lyme Disease.
    J Clin Invest. 1994 Jul;94(1):454-7 PMID: 8040289
  48. Nucleotide sequence and analysis of the gene in Borrelia burgdorferi encoding the immunogenic P39 antigen.
    FEMS Microbiol Lett. 1994 Jun 15;119(3):381-7 PMID: 8050720
  49. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment.
    J Infect Dis. 1994 Nov;170(5):1312-6 PMID: 7963735
  50. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.
    Infect Immun. 1993 Nov;61(11):4696-702 PMID: 8406868
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1995-06-00
Pages
2255-61
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC173294
Subset
IM
Grants
NIAID NIH HHS · AI26815 · United States
NIAID NIH HHS · AI30548 · United States
NIAID NIH HHS · AI32403 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]